Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Non-cash Items (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Non-cash Items for 15 consecutive years, with $3.3 billion as the latest value for Q4 2025.

  • Quarterly Non-cash Items fell 14.5% to $3.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.3 billion through Dec 2025, down 14.5% year-over-year, with the annual reading at $3.3 billion for FY2025, 14.5% down from the prior year.
  • Non-cash Items hit $3.3 billion in Q4 2025 for Perspective Therapeutics, down from $3.8 billion in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $6.7 billion in Q4 2023 to a low of $2000.0 in Q2 2022.
  • Historically, Non-cash Items has averaged $1.2 billion across 5 years, with a median of $9.0 million in 2021.
  • Biggest five-year swings in Non-cash Items: crashed 99.8% in 2022 and later soared 685200.0% in 2023.
  • Year by year, Non-cash Items stood at $4.1 million in 2021, then tumbled by 99.95% to $2000.0 in 2022, then skyrocketed by 333562650.0% to $6.7 billion in 2023, then tumbled by 42.76% to $3.8 billion in 2024, then decreased by 14.5% to $3.3 billion in 2025.
  • Business Quant data shows Non-cash Items for CATX at $3.3 billion in Q4 2025, $3.8 billion in Q4 2024, and $6.7 billion in Q4 2023.